HCG and Fertility on TRT: How to Preserve Reproductive Function While on Testosterone

Exogenous testosterone shuts down the hypothalamic-pituitary-gonadal (HPG) axis through negative feedback. When testosterone levels are high from external administration, the brain stops signaling the testes to produce testosterone and sperm. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) drop to near zero, and without these signals, intratesticular testosterone (ITT) — the local testosterone concentration within the testes that drives spermatogenesis — falls by 90-95%. The result: testicular atrophy (the testes physically shrink because they are no longer producing testosterone or sperm) and significantly reduced or absent sperm production. For men who want to maintain fertility while on TRT, human chorionic gonadotropin (HCG) is the primary intervention. HCG mimics LH — it binds to the same receptor on Leydig cells in the testes and stimulates intratesticular testosterone production. By maintaining ITT, HCG preserves the hormonal environment needed for spermatogenesis even while exogenous testosterone suppresses pituitary LH and FSH. The key distinction: HCG replaces LH signaling but does not replace FSH. LH drives testosterone production in the testes (which HCG handles). FSH directly stimulates Sertoli cells, which support sperm maturation. For many men, maintaining ITT through HCG is sufficient to preserve some level of sperm production. For others — especially those on TRT for extended periods — HCG alone is not enough and FSH support (via HMG or recombinant FSH) may be needed. This is not theoretical. A 2019 study in the Journal of Clinical Endocrinology & Metabolism found that men on TRT without HCG had a median sperm concentration of 1.5 million/mL (severely oligospermic), while men on TRT with concurrent HCG maintained a median of 8.7 million/mL — still below normal (15 million/mL threshold) but in a range where conception is possible, particularly with assisted reproduction if needed. This content is for research and educational purposes only. Always consult a qualified healthcare professional before making protocol changes.

HCG dosing for fertility preservation on TRT varies across providers, but the clinical literature and TRT specialty practices have converged on a few common protocols. Standard fertility preservation dose: 500 IU subcutaneously every other day (approximately 1,500 IU/week in three injections). This is the most commonly cited protocol in the urology and endocrinology literature for maintaining ITT during testosterone therapy. Some providers use 250 IU daily (1,750 IU/week) for steadier levels. Minimal maintenance dose: 250 IU every other day (approximately 750 IU/week). This lower dose may maintain testicular volume and some spermatogenesis in men who are primarily concerned about atrophy rather than active fertility. It is often used as a baseline protocol with the option to increase if conception is planned. Pre-conception protocol: some providers increase to 1,000-1,500 IU three times per week (3,000-4,500 IU/week) for 3-6 months before planned conception, sometimes combined with a reduction in testosterone dose. The logic: higher HCG stimulation maximizes ITT, and lower exogenous testosterone reduces HPG axis suppression, allowing partial recovery of FSH. Timing matters. Starting HCG at the same time as TRT produces better fertility outcomes than adding HCG after months or years of TRT-only therapy. Once the testes have been suppressed for an extended period, recovery of spermatogenesis takes longer and may be incomplete. Dr. Larry Lipshultz's group at Baylor found that men who started HCG concurrently with TRT maintained sperm counts 3-4x higher than those who added HCG after 6+ months of unsupported TRT. HCG is typically reconstituted from lyophilized (freeze-dried) powder with bacteriostatic water. Standard reconstitution: 5,000 IU vial with 5 mL bacteriostatic water = 1,000 IU/mL. For a 500 IU dose, you draw 0.5 mL (50 units on an insulin syringe). Store reconstituted HCG refrigerated and use within 30-60 days depending on the pharmacy's recommendation. Dosed tracks HCG alongside testosterone doses on a single timeline, making it easy to see your complete protocol at a glance.

For some men, HCG alone does not restore sperm production to a level sufficient for conception. This is more common in men who were on TRT without HCG for years before deciding they want children, men with pre-existing fertility issues (varicocele, genetic factors), and men over 40 whose baseline fertility is already declining. The missing piece is FSH. HCG mimics LH and maintains intratesticular testosterone, but FSH directly stimulates Sertoli cells — the cells that nurse developing sperm through the maturation process. Without FSH, you can have adequate ITT but still produce very few mature sperm. HMG (human menopausal gonadotropin) is the most commonly prescribed FSH source for male fertility. It contains both LH and FSH activity. Typical dose: 75-150 IU intramuscularly or subcutaneously three times per week, combined with HCG. Brand names include Menopur and Repronex. The cost is significant — $200-600 per month depending on dose and pharmacy. Recombinant FSH (Gonal-F, Follistim) is a purer FSH source without LH activity. It is more expensive ($300-800/month) but allows precise FSH dosing without additional LH stimulation (which HCG already provides). Some fertility specialists prefer rFSH + HCG over HMG + HCG for this reason. The typical recovery timeline when adding FSH support: 3-6 months before meaningful sperm production returns. Spermatogenesis takes approximately 74 days from stem cell to mature sperm, so even with optimal hormonal support, you need at least 2-3 full sperm production cycles before a semen analysis shows improvement. Patience is not optional — checking semen analysis monthly in the first 3 months leads to discouragement from predictably low numbers. For men who want to conceive: the most conservative approach is to discontinue TRT entirely and use HCG + HMG/FSH to restart the HPG axis while maintaining testosterone through HCG-stimulated intratesticular production. This produces the best fertility outcomes but means accepting lower serum testosterone levels (HCG-stimulated testosterone is typically 400-600 ng/dL vs 800-1200 ng/dL on replacement doses). Some men feel noticeably worse on HCG-only testosterone, which creates a quality-of-life trade-off during the conception period. Dosed allows you to track semen analysis results, HCG doses, HMG/FSH doses, and testosterone levels together — giving your provider a complete picture of protocol response.

Here is the uncomfortable truth that not every TRT provider communicates clearly: testosterone replacement therapy is not reliable male contraception, but it does significantly impair fertility in most men. About 90% of men on TRT experience severe oligospermia (very low sperm count) or azoospermia (zero sperm) within 3-6 months. For 10%, some sperm production persists — which is why TRT is not approved as a contraceptive (it is not reliable enough). The reversibility question: for most men, spermatogenesis recovers after TRT discontinuation, but it is not guaranteed and it is not fast. A 2019 meta-analysis found that 90% of men recovered to a sperm concentration of 20 million/mL within 12 months of stopping TRT. But 10% did not. And the recovery time varied from 3 months to over 24 months. Factors that predict slower or incomplete recovery: older age at the time of TRT, longer duration of TRT, higher doses, and pre-existing fertility issues. If you are a man of reproductive age starting TRT and there is any possibility you might want children in the future: bank sperm before starting TRT. Sperm banking costs $300-1,000 for the initial analysis and freezing, plus $300-500/year for storage. This is the single best insurance policy for your fertility, because it eliminates the uncertainty of whether recovery will be adequate when you need it. Start HCG concurrently with TRT if preserving fertility without banking is important. Do not wait until you want to conceive to add HCG — the earlier you start, the better the testicular preservation. Get a baseline semen analysis before starting TRT. You cannot assess the impact of TRT on your fertility if you do not know where you started. Some men have pre-existing fertility issues that they discover only when they try to conceive years later — knowing your baseline separates TRT effects from pre-existing conditions. Monitor with periodic semen analysis (every 6-12 months) if fertility preservation is a goal. Dosed can remind you when labs are due and track results over time to show your provider the full fertility picture alongside your protocol data.